Local Institution - 0279 — New York, New York

Local Institution - 0279 is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 0279 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Pancreatic Ductal Adenocarcinoma, Breast Neoplasms.

Sponsors: Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0279?

Local Institution - 0279 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0279 conducted?

Local Institution - 0279 has 2 clinical trials on record, with 2 currently active. Their work covers Pancreatic Ductal Adenocarcinoma, Breast Neoplasms.

Is Local Institution - 0279 accredited by Crixeo Health?

Local Institution - 0279 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0279?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.